Article · 29 Aug 2026
Conference abstract
Designing tumor immunotherapy amidst tumor heterogeneity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer is a highly heterogeneous disease and mutations that occur in genes vary patient to patient. Further, recent studies using deep sequencing technology reveal that tumor tissue exhibit high degree of intratumoral heterogeneity harboring multiple clonal populations with the tumor. Therefore, the use of established cell lines as therapeutic vaccines may not represent all the clonal populations and will not be efficacious. Our laboratory has pioneered the development of a therapeutic cancer vaccine design that uses tumor membrane vesicles (TMVs) prepared from tumor tissue and a novel protein transfer technology to adjuvantate them. Using this approach it is feasible to develop cancer vaccines from surgically removed tumor tissues which incorporates all the antigenic variations found in the tissue. In this technology, immunostimulatory molecules are attached to a glycolipid and then tethered to tumor membranes by a short-incubation, thus eliminating the need for gene transfer or live cells to develop cancer vaccines. The immunostimulatory molecules incorporated onto tumor membranes serve as adjuvants to boost antitumor immunity against tumor-associated antigens expressed on cancer cell membranes. Experiments using mouse models of cancers have shown that membrane-based cancer vaccines prepared by protein transfer technology can protect mice from live tumor cell challenge suggesting that membrane-based cancer vaccines induce protective antitumor immunity. This personalized therapeutic vaccine approach has the potential to treat cancers where the target antigen is yet to be identified.
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Periasamy Selvaraj”